Institutional investors hold a majority ownership of IMGN through the 83.93% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MEDICAL STRATEGY GMBH Bought 168.7 Thousand shares of ImmunoGen Inc
MEEDER ASSET MANAGEMENT, INC. Bought 16.2 Thousand shares of ImmunoGen Inc
RELIANCE TRUST COMPANY OF DELAWA... Bought 9.6 Thousand shares of ImmunoGen Inc